Researchers assessed the benefit of early vs late endoscopic retrograde cholangiopancreatography in hospitalized patients with acute biliary pancreatitis.
Researchers analyzed the incidence of gallstone disease within 1 year prior to pancreatic ductal adenocarcinoma.
A team of researchers analyzed the safety, efficacy, and tolerability of seladelpar in patients with compensated liver cirrhosis resulting from primary biliary cholangitis.
Use of GLP-1 RAs is associated with increased risks for gallbladder or biliary diseases, with a higher risk for GLP-1 RA use in weight loss.
Researchers examined factors linked to using neoadjuvant and adjuvant chemotherapy in individuals with resectable gallbladder cancer.
Researchers sought to compare EUS and MRCP to determine sensitivity and specificity in diagnosing choledocholithiasis in an intermediate likelihood group.
Researchers assessed the effect of preoperative intravenous NSAIDs on postoperative pain relief in patients who underwent laparoscopic cholecystectomy.
Investigators assessed trends and patterns of healthcare spending in patients with GI malignancies in the US and predicted spending estimates for the next decade.
No statistically significant differences in complications, mortality, or reintervention requirements were seen between the groups.
Investigators created and assessed the validity of an ultrasound-based scoring system to distinguish cholesterol polyps vs adenomatous polyps in the gallbladder.
Investigators assessed the effects of treatment with acupoint catgut embedding plus tauroursodeoxycholic acid on symptom improvement in patients with gallstones.
The treatment is expected to reprogram the immune system to induce tolerance to PDC-E2.
Investigators assessed the efficacy of ursodeoxycholic acid in preventing symptomatic gallstone disease among patients undergoing bariatric surgery.
Investigators assessed neurocognitive and motor development of children with biliary atresia and identified risk factors for impaired development.
Investigators assessed how certain factors influence the prevalence of primary sclerosing cholangitis in patients with inflammatory bowel disease.
A new model could help surgeons predict the probability of pain reduction following cholecystectomy and inform decisions regarding which patients with uncomplicated cholelithiasis could benefit from surgery.
Investigators evaluated the antitumor activity of infigratinib in patients with previously treated, locally advanced or metastatic cholangiocarcinoma and FGFR2 alterations.
Researchers summarized the reciprocal interaction between sleep and liver diseases, including cirrhosis, and investigated potential approaches for therapeutic interventions.
The approval was based on data from the double-blind, placebo-controlled ClarIDHy study.
Investigators described a syndrome of cholangiopathy in patients recovering from severe COVID-19 with abnormal liver tests and bile duct injury.